Yang W et al., Immune signature profiling identified prognostic factors for gastric cancer., , Chin J Cancer Res, Jun 01, 2019 ➔

Bodelon C et al., Molecular classification of epithelial ovarian cancer based on methylation profiling: evidence for survival heterogeneity., , Clin Cancer Res., May 29, 2019 ➔

Lopez-Bujanda ZA et al., Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression, , bioRxiv, May 28, 2019 ➔

Ghatalia P et al., Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma., , J Immunother Cancer., May 28, 2019 ➔

Ji N et al., Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial., , Oncoimmunology., May 25, 2019 ➔

Theelen WSME Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer., , PLoS One, May 24, 2019 ➔

Monteiro AC et al., Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma., , Mol Oncol., May 23, 2019 ➔

Young LA et al., Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress, , Cancer Res, May 23, 2019 ➔

Ragulan C et al., Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes., , Sci Rep, May 21, 2019 ➔

Pinskaya M et al., Blind exploration of the unreferenced transcriptome reveals novel RNAs for prostate cancer diagnosis, , bioRxiv, May 21, 2019 ➔

Klintman J et al., Differential genomic and transcriptomic events associated with high-grade transformation of Chronic Lymphocytic Leukemia, , bioRxiv, May 21, 2019 ➔

Sharma N et al., TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion., , Proc Natl Acad Sci U S A., May 21, 2019 ➔

Baeuerle PA et al., Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response., , Nat Commun, May 21, 2019 ➔

Segovia M et al., Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation, , Cancer Cell, May 21, 2019 ➔

Song Y et al., High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia, , J Transl Med., May 20, 2019 ➔